Ashraf Aminorroaya

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

Scientific reports

Diabetes, metabolic syndrome and obesity : targets and therapy

International journal of hypertension

Journal of diabetes investigation

Isfahan University of Medical Sciences

University of Isfahan (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Isfahan University of Medical Sciences

Iran

Professor :: Internal Medicine

Isfahan University of Medical Sciences

Iran

Associate professor :: Internal medicine

Isfahan University of Medical Sciences Oct 16 1993 - Jul 16 2001

Iran

assistant professor :: Internal Medicine

Kashan University of Medical Sciences Oct 16 1992 - Oct 15 1993

Iran

Assistant professor :: Internal Medicine

Education History

University of Isfahan Sep 23 1983 - Aug 22 1989

Iran

PHD :: Medical Faculty

Publications

Mozhgan Karimifar, Jamileh Afsar, Massoud Amini, Firouzeh Moeinzadeh, Awat Feizi, Ashraf Aminorroaya
The effect of linagliptin on microalbuminuria in patients with diabetic nephropathy: a randomized, double blinded clinical trial. Scientific reports 13 (1) (2023)
Mozhgan Karimifar, Jamileh Afsar, Massoud Amini, Firouzeh Moeinzadeh, Awat Feizi, Ashraf Aminorroaya
The effect of linagliptin on microalbuminuria in patients with diabetic nephropathy: a randomized, double blinded clinical trial. Scientific reports 13 (1) (2023)
Mozhgan Karimifar, Jamileh Afsar, Massoud Amini, Firouzeh Moeinzadeh, Awat Feizi, Ashraf Aminorroaya
The effect of linagliptin on microalbuminuria in patients with diabetic nephropathy: a randomized, double blinded clinical trial. Scientific reports 13 (1) (2023)
Samaneh Shahrokh Esfahani, Aliye Tabatabaee, Ashraf Aminorroaya, Massoud Amini, Awat Feizi, Mohsen Janghorbani, Azamosadat Tabatabaei, Rokhsareh Meamar, Atoosa Adibi, Majid Abyar, Mozhgan Karimifar, Raheleh Sajad, Rezvan Salehidoost, Elham Faghih Imani, Silva Hovsepian, Mehri Sirous, Sima Aminorroaya Yamini
Isfahan Thyroid Cohort Study (ITCS). Archives of Iranian medicine 24 (11) (2021)
Maryam Kianpour, Ashraf Aminorroaya, Massoud Amini, Awat Feizi, Mohsen Janghorbani, Saeideh Shokri, Sima Aminorroaya Yamini, Maryam Farghadani, Ali Hekmatnia, Hossien Gharib
Reference Intervals for Thyroid Hormones During the First Trimester of Gestation: A Report from an Area with a Sufficient Iodine Level. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 53 (9) (2021)
Erfan Sadeghi, Sayed Mohsen Hosseini, Mehrdad Vossoughi, Ashraf Aminorroaya, Massoud Amini
Association of Lipid Profile with Type 2 Diabetes in First-Degree Relatives: A 14-Year Follow-Up Study in Iran. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)
Roqayeh Aliyari, Ebrahim Hajizadeh, Ashraf Aminorroaya, Farshad Sharifi, Iraj Kazemi, Ahmad-Reza Baghestani
Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)
Maryam Kianpour, Ashraf Aminorroaya, Massoud Amini, Awat Feizi, Sima Aminorroaya Yamini, Mohsen Janghorbani
Thyroid-stimulating hormone (TSH) serum levels and risk of spontaneous abortion: A prospective population-based cohort study. Clinical endocrinology 91 (1) (2019)
Maryam Karimi Fard, Ashraf Aminorroaya, Ali Kachuei, Mohammad Reza Salamat, Moluk Hadi Alijanvand, Sima Aminorroaya Yamini, Mansoor Karimifar, Awat Feizi, Massoud Amini
Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple-blind clinical trial. Journal of diabetes investigation 10 (3) (2018)
Rezvan Salehidoost, Asieh Mansouri, Massoud Amini, Sima Aminorroaya Yamini, Ashraf Aminorroaya
Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus. Acta diabetologica 55 (6) (2018)
Mohsen Janghorbani, Ashraf Aminorroaya, Masoud Amini
Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors. International journal of hypertension 2017 (2017)

Ashraf Aminorroaya.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ashraf Aminorroaya